These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 31409888)
21. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma. Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140 [TBL] [Abstract][Full Text] [Related]
22. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells. Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160 [TBL] [Abstract][Full Text] [Related]
23. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome. Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668 [TBL] [Abstract][Full Text] [Related]
24. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks. Palechor-Ceron N; Krawczyk E; Dakic A; Simic V; Yuan H; Blancato J; Wang W; Hubbard F; Zheng YL; Dan H; Strome S; Cullen K; Davidson B; Deeken JF; Choudhury S; Ahn PH; Agarwal S; Zhou X; Schlegel R; Furth PA; Pan CX; Liu X Cells; 2019 Oct; 8(11):. PubMed ID: 31717887 [TBL] [Abstract][Full Text] [Related]
25. N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells. Feduska JM; Garcia PL; Brennan SB; Bu S; Council LN; Yoon KJ BMC Cancer; 2013 May; 13():261. PubMed ID: 23714211 [TBL] [Abstract][Full Text] [Related]
26. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma. Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; RaschellĂ G; Melino G Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555 [TBL] [Abstract][Full Text] [Related]
27. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation. Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509 [TBL] [Abstract][Full Text] [Related]
28. The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line. Yi B; Yang J; Wang L Tumour Biol; 2014 Apr; 35(4):3229-35. PubMed ID: 24293393 [TBL] [Abstract][Full Text] [Related]
29. Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours. Chen L; Esfandiari A; Reaves W; Vu A; Hogarty MD; Lunec J; Tweddle DA Int J Oncol; 2018 Mar; 52(3):967-977. PubMed ID: 29393340 [TBL] [Abstract][Full Text] [Related]
30. PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma. Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957039 [TBL] [Abstract][Full Text] [Related]
31. Anti-tumor effect of sulfasalazine in neuroblastoma. Mooney MR; Geerts D; Kort EJ; Bachmann AS Biochem Pharmacol; 2019 Apr; 162():237-249. PubMed ID: 30639262 [TBL] [Abstract][Full Text] [Related]
32. Generation and characterization of novel local and metastatic human neuroblastoma variants. Nevo I; Sagi-Assif O; Edry Botzer L; Amar D; Maman S; Kariv N; Leider-Trejo LE; Savelyeva L; Schwab M; Yron I; Witz IP Neoplasia; 2008 Aug; 10(8):816-27. PubMed ID: 18683320 [TBL] [Abstract][Full Text] [Related]
33. A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model. Cao D; Kishida S; Huang P; Mu P; Tsubota S; Mizuno M; Kadomatsu K PLoS One; 2014; 9(1):e86813. PubMed ID: 24466252 [TBL] [Abstract][Full Text] [Related]
34. MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Alam G; Cui H; Shi H; Yang L; Ding J; Mao L; Maltese WA; Ding HF Am J Pathol; 2009 Aug; 175(2):856-66. PubMed ID: 19608868 [TBL] [Abstract][Full Text] [Related]
35. From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models. Capasso M; Brignole C; Lasorsa VA; Bensa V; Cantalupo S; Sebastiani E; Quattrone A; Ciampi E; Avitabile M; Sementa AR; Mazzocco K; Cafferata B; Gaggero G; Vellone VG; Cilli M; Calarco E; Giusto E; Perri P; Aveic S; Fruci D; Tondo A; Luksch R; Mura R; Rabusin M; De Leonardis F; Cellini M; Coccia P; Iolascon A; Corrias MV; Conte M; Garaventa A; Amoroso L; Ponzoni M; Pastorino F J Transl Med; 2024 Feb; 22(1):151. PubMed ID: 38351008 [TBL] [Abstract][Full Text] [Related]
36. Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma. Hallett RM; Seong AB; Kaplan DR; Irwin MS Mol Oncol; 2016 Nov; 10(9):1461-1472. PubMed ID: 27599694 [TBL] [Abstract][Full Text] [Related]
37. Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Chang HH; Lee H; Hu MK; Tsao PN; Juan HF; Huang MC; Shih YY; Wang BJ; Jeng YM; Chang CL; Huang SF; Tsay YG; Hsieh FJ; Lin KH; Hsu WM; Liao YF Clin Cancer Res; 2010 Sep; 16(17):4411-20. PubMed ID: 20736329 [TBL] [Abstract][Full Text] [Related]
38. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms. Zins K; Kovatchki D; Lucas T; Abraham D Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225 [TBL] [Abstract][Full Text] [Related]
39. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma. Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423 [TBL] [Abstract][Full Text] [Related]